What was the market valuation of the US weight loss-supplements market in 2024?

The market valuation was $9.65 Billion in 2024. Read More

What is the projected market valuation for the US weight loss-supplements market by 2035?

The projected valuation for 2035 is $176.32 Billion. Read More

What is the expected CAGR for the US weight loss-supplements market during the forecast period 2025 - 2035?

The expected CAGR is 30.23% during the forecast period 2025 - 2035. Read More

Which segment had the highest valuation in the US weight loss-supplements market in 2024?

The Meal Replacement segment had the highest valuation at $2.5 Billion in 2024. Read More

What is the projected valuation for the Fat Burners segment by 2035?

The Fat Burners segment is projected to reach $35.0 Billion by 2035. Read More

Which formulation type is expected to dominate the US weight loss-supplements market by 2035?

The Capsule formulation type is expected to dominate, projected at $60.0 Billion by 2035. Read More

What distribution channel is anticipated to have the largest market share in 2035?

Online Retail is anticipated to have the largest market share, projected at $70.0 Billion by 2035. Read More

Which age group contributed the most to the US weight loss-supplements market in 2024?

The 36-45 age group contributed the most, with a valuation of $2.5 Billion in 2024. Read More

What is the projected market size for the Dietary Fiber Supplements segment by 2035?

The Dietary Fiber Supplements segment is projected to reach $51.32 Billion by 2035. Read More

US Weight Loss Supplements Market

Q: Who are the key players in the US weight loss-supplements market?

Key players include Herbalife, Nutrisystem, Weight Watchers, GNC Holdings, Isagenix, Bariatric Fusion, SlimFast, and Nature's Way. Read More

ID: MRFR/FnB/18301-HCR

100 Pages

Garvit Vyas

Last Updated: April 06, 2026

US Weight Loss Supplements Market Size, Share, Industry Trend & Analysis Research Report By Type (Meal Replacement, Fat Burners, Appetite Suppressants, Thermogenic Supplements, Dietary Fiber Supplements), By Formulation (Powder, Capsule, Liquid, Tablet, Bar), By Consumer Age Group (18–25, 26–35, 36–45, 46–55, 56 and above), By Distribution Channel (Supermarkets/Hypermarkets, Health and Wellness Stores, Online Retail, Pharmacies, Fitness Centers) Forecast to 2035

US Weight Loss Supplements Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)30.23%

2024 Market Size$ 9.65 Billion

2025 Market Size$ 12.56 Billion

2035 Market Size$ 176.32 Billion

Key Players

Herbalife

Nutrisystem

Weight Watchers

GNC Holdings

Isagenix

Bariatric Fusion

Trends

Natural Ingredients Dominance
Personalized Nutrition
Digital Influence on Purchasing

Opportunities

Rising Obesity Rates
Increased Health Awareness
Evolving Consumer Preferences

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Type (USD Billion)
  1. 4.1.1 Meal Replacement
  2. 4.1.2 Fat Burners
  3. 4.1.3 Appetite Suppressants
  4. 4.1.4 Thermogenic Supplements
  5. 4.1.5 Dietary Fiber Supplements
2. 4.2 Pharmaceutical, BY Formulation (USD Billion)
  1. 4.2.1 Powder
  2. 4.2.2 Capsule
  3. 4.2.3 Liquid
  4. 4.2.4 Tablet
  5. 4.2.5 Bar
3. 4.3 Pharmaceutical, BY Distribution Channel (USD Billion)
  1. 4.3.1 Supermarkets/Hypermarkets
  2. 4.3.2 Health and Wellness Stores
  3. 4.3.3 Online Retail
  4. 4.3.4 Pharmacies
  5. 4.3.5 Fitness Centers
4. 4.4 Pharmaceutical, BY Consumer Age Group (USD Billion)
  1. 4.4.1 18-25
  2. 4.4.2 26-35
  3. 4.4.3 36-45
  4. 4.4.4 46-55
  5. 4.4.5 56 and above
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Herbalife (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Nutrisystem (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Weight Watchers (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 GNC Holdings (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Isagenix (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Bariatric Fusion (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 SlimFast (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Nature's Way (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TYPE
3. 6.3 US MARKET ANALYSIS BY FORMULATION
4. 6.4 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 US MARKET ANALYSIS BY CONSUMER AGE GROUP
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Billion)
14. 6.14 PHARMACEUTICAL, BY FORMULATION, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY FORMULATION, 2024 TO 2035 (USD Billion)
16. 6.16 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
18. 6.18 PHARMACEUTICAL, BY CONSUMER AGE GROUP, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY CONSUMER AGE GROUP, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY FORMULATION, 2025-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
  4. 7.2.4 BY CONSUMER AGE GROUP, 2025-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Billion, 2025-2035)

Meal Replacement
Fat Burners
Appetite Suppressants
Thermogenic Supplements
Dietary Fiber Supplements

Pharmaceutical By Formulation (USD Billion, 2025-2035)

Powder
Capsule
Liquid
Tablet
Bar

Pharmaceutical By Distribution Channel (USD Billion, 2025-2035)

Supermarkets/Hypermarkets
Health and Wellness Stores
Online Retail
Pharmacies
Fitness Centers

Pharmaceutical By Consumer Age Group (USD Billion, 2025-2035)

18-25
26-35
36-45
46-55
56 and above

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”